Glaukos (GKOS) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Glaukos (GKOS) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 7.96% |
| 10 | Glaukos | 11.02 Bn | 10.90 Bn | 151.59 Mn | 2.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.98% |
| Mar 31, 2026 | 4.57% |
| Dec 31, 2025 | 6.26% |
| Sep 30, 2025 | 8.31% |
| Jun 30, 2025 | 11.38% |
| Mar 31, 2025 | 9.02% |
| Dec 31, 2024 | 12.37% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 22.61% |
| Mar 31, 2024 | 32.98% |
| Dec 31, 2023 | 62.60% |
| Sep 30, 2023 | 63.91% |
| Mar 31, 2023 | 62.87% |
| Dec 31, 2022 | 62.36% |
| Sep 30, 2022 | 63.33% |
| Jun 30, 2022 | 58.05% |
| Mar 31, 2022 | 56.38% |
| Dec 31, 2021 | 53.28% |
| Sep 30, 2021 | 70.36% |
| Jun 30, 2021 | 65.22% |